Douwe F. Samplonius
- Immunology top 5%
- Molecular Biology
- Oncology top 10%
- Radiology, Nuclear Medicine and Imaging top 10%
- Biotechnology top 10%
- Co-authors
- Wijnand HelfrichEdwin BremerLou F. M. H. de LeijBram ten CateRobert J. van GinkelMarco de BruynValerie R. WiersmaLou de Leij
- Topics
- CAR-T cell therapy research (10 papers)Cell death mechanisms and regulation (10 papers)Immune Cell Function and Interaction (7 papers)
- Cited by
- ImmunologyOncologyBiotechnology
- Partner nations
- NetherlandsChinaUnited Kingdom
In The Last Decade
Douwe F. Samplonius
38 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 68
- Immunology 570
- Molecular Biology 547
- Oncology 387
- Radiology, Nuclear Medicine and Imaging 195
- Biotechnology 83
Countries citing papers authored by Douwe F. Samplonius
This map shows the geographic impact of Douwe F. Samplonius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douwe F. Samplonius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douwe F. Samplonius more than expected).
Fields of papers citing papers by Douwe F. Samplonius
This network shows the impact of papers produced by Douwe F. Samplonius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douwe F. Samplonius. The network helps show where Douwe F. Samplonius may publish in the future.
Co-authorship network of co-authors of Douwe F. Samplonius
This figure shows the co-authorship network connecting the top 25 collaborators of Douwe F. Samplonius. A scholar is included among the top collaborators of Douwe F. Samplonius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douwe F. Samplonius. Douwe F. Samplonius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 2 | |
| 4 | 8 | |
| 5 | 22 | |
| 6 | 10 | |
| 7 | 6 | |
| 8 | 36 | |
| 9 | 25 | |
| 10 | 23 | |
| 11 | 49 | |
| 12 | 15 | |
| 13 | 33 | |
| 14 | 50 | |
| 15 | 26 | |
| 16 | 18 | |
| 17 | 37 | |
| 18 | 81 | |
| 19 | 46 | |
| 20 | 75 |
About Douwe F. Samplonius
Douwe F. Samplonius is a scholar working on Immunology, Physiology and Oncology, having authored 39 papers that have together received 1.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Cell death mechanisms and regulation (10 papers) and Immune Cell Function and Interaction (7 papers). The work is most often cited by research in Immunology (570 citations), Oncology (387 citations) and Biotechnology (83 citations). Douwe F. Samplonius has collaborated with scholars based in Netherlands, China and United Kingdom. Frequent co-authors include Wijnand Helfrich, Edwin Bremer, Lou F. M. H. de Leij, Bram ten Cate, Robert J. van Ginkel, Marco de Bruyn, Valerie R. Wiersma, Lou de Leij, Hans W. Nijman and Bart‐Jan Kroesen. Their work appears in journals such as Journal of Biological Chemistry, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.